Litcius/Paper detail

Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience

Tracy L. Rose, William H. Weir, Gregory M. Mayhew, Yoichiro Shibata, Patrick Eulitt, Joshua M. Uronis, Mi Zhou, Matthew E. Nielsen, Angela B. Smith, Michael Woods, Michele C. Hayward, Ashley H. Salazar, Matthew I. Milowsky, Sara E. Wobker, Katrina McGinty, Michael V. Millburn, Joel R. Eisner, William Y. Kim

2021British Journal of Cancer193 citationsDOIOpen Access PDF

Topics & Concepts

Immune checkpointImmune systemCancer researchImmunotherapyBladder cancerCancerCD8Tumor microenvironmentBiologyMedicineOncologyInternal medicineImmunologyBladder and Urothelial Cancer TreatmentsFibroblast Growth Factor ResearchCancer Immunotherapy and Biomarkers
Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience | Litcius